Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice - Concepedia

Concepedia

Publication | Open Access

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

DOI Full Paper Access

405

Citations

39

References

2009

Year

Alessandro Pocai, Paul E. Carrington, Jennifer R. Adams, Michael Wright, George J. Eiermann, Lan Zhu, Xiaobing Du, Aleksandr Petrov, Michael E. Lassman, Guoqiang Jiang,

Abstract

Sustained GLP1R/GCGR dual agonism reverses obesity in DIO mice and is a novel therapeutic approach to the treatment of obesity.

References

	Year	Citations
Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice Jing Xu, David J. Lloyd, Clarence Hale, Diabetes	2008	1.1K
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study Daniel J. Drucker, John B. Buse, Kristin Taylor, The Lancet Non-pharmacological InterventionDiabetes ManagementInsulin ManagementDiabetesType 2	2008	1.1K
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene Louise A. Scrocchi, Theodore J. Brown, Neil J. MacLusky, Nature Medicine Metabolic SyndromeInsulin SignalingSignal TransductionG Protein-coupled ReceptorInsulin Management	1996	788
Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice Richard W. Gelling, Xiaoqing Du, Darwin S. Dichmann, Proceedings of the National Academy of Sciences	2003	552
Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects Katie Wynne, Adrian J. Park, Caroline J. Small, Diabetes	2005	429
Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure Laurie L. Baggio, Qingling Huang, Theodore J. Brown, Gastroenterology ObesityNutritionEnergy HomeostasisAppetite ControlEnergy Expenditure	2004	368
Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial Katie Wynne, A J Park, C. J. Small, International Journal of Obesity ObesityMetabolic SyndromeNutritionEnergy MetabolismEnergy Homeostasis	2006	357
Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable Cathrine Ørskov, André Wettergren, Jens J. Holst Diabetes Healthy SubjectsGlucagonlike Peptide-1 7–36Peptide SciencePeptide TherapeuticsInsulin Signaling	1993	315
Oxyntomodulin Inhibits Food Intake in the Rat C. L. Dakin, I. Gunn, C. J. Small, Endocrinology	2001	283
The Glucagon Receptor Is Required for the Adaptive Metabolic Response to Fasting Christine Longuet, Elaine M. Sinclair, Adriano Maida, Cell Metabolism Metabolic SyndromeAdaptive Metabolic ResponseEnergy HomeostasisMolecular PhysiologySignal Transduction	2008	259

Page 1